— Know what they know.
Not Investment Advice
Also trades as: NAMSW (NASDAQ) · $vol 0M

NAMS NASDAQ

NewAmsterdam Pharma Company N.V.
1W: +2.8% 1M: -9.3% 3M: -33.5% YTD: -34.1% 1Y: -21.0% 3Y: +154.9% 5Y: +135.5%
$23.20
-0.96 (-3.97%)
 
Weekly Expected Move ±8.4%
$19 $21 $23 $25 $27
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $2.7B mcap · 80M float · 1.64% daily turnover · Short 49% of daily vol

📊 Key Metrics

TTM
$7M
Revenue
-88.9% YoY
$-260M
Net Income
-56.6% YoY
$-144M
Free Cash Flow
-15.6% YoY
100.0%
Gross Margin
-1752.6%
Op. Margin
-1732.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-36.8%
ROA-34.2%
ROIC8216.2%

Valuation

P/E-10.6
P/B4.5
EV/EBITDA-13.9

Leverage

Debt/Equity0.00
Current Ratio9.03
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z32.43
Beneish M-4.66

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms